Well­come looks for back­ers of an $8B-plus Covid-19 fund; ReNeu­ron signs on an­oth­er phar­ma part­ner

→ The non­prof­it Well­come is look­ing to raise $8 bil­lion to fund the de­vel­op­ment of new drugs and vac­cines that can fight Covid-19. The UK or­ga­ni­za­tion says that rep­re­sents just a frac­tion of the mon­ey that’s been set aside to safe­guard economies and would go a long way to fund­ing an ef­fec­tive R&D cam­paign while scal­ing up man­u­fac­tur­ing along­side the ef­fort. Dubbed Covid-Ze­ro, they’re hop­ing to have at least $8 bil­lion in the fund by the end of this month. “Busi­ness­es and gov­ern­ments are right­ly con­cerned with tack­ling im­me­di­ate con­cerns – how to sup­port staff, keep trad­ing and bol­ster economies. But we al­so need a way out of this pan­dem­ic as fast as pos­si­ble,” not­ed Je­re­my Far­rar, who runs Well­come.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER